WO2010041913A3 - Grs 단백질 또는 이의 단편의 신규한 용도 - Google Patents

Grs 단백질 또는 이의 단편의 신규한 용도 Download PDF

Info

Publication number
WO2010041913A3
WO2010041913A3 PCT/KR2009/005829 KR2009005829W WO2010041913A3 WO 2010041913 A3 WO2010041913 A3 WO 2010041913A3 KR 2009005829 W KR2009005829 W KR 2009005829W WO 2010041913 A3 WO2010041913 A3 WO 2010041913A3
Authority
WO
WIPO (PCT)
Prior art keywords
fragments
proteins
grs
grs proteins
novel uses
Prior art date
Application number
PCT/KR2009/005829
Other languages
English (en)
French (fr)
Other versions
WO2010041913A9 (ko
WO2010041913A2 (ko
Inventor
김성훈
박민철
Original Assignee
서울대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서울대학교산학협력단 filed Critical 서울대학교산학협력단
Priority to EP09819420.2A priority Critical patent/EP2351575B1/en
Priority to US13/123,522 priority patent/US8901081B2/en
Publication of WO2010041913A2 publication Critical patent/WO2010041913A2/ko
Publication of WO2010041913A3 publication Critical patent/WO2010041913A3/ko
Publication of WO2010041913A9 publication Critical patent/WO2010041913A9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y601/00—Ligases forming carbon-oxygen bonds (6.1)
    • C12Y601/01—Ligases forming aminoacyl-tRNA and related compounds (6.1.1)
    • C12Y601/01014—Glycine-tRNA ligase (6.1.1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/53—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/867—Retroviral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

본 발명은 전체길이의 GRS 단백질 또는 이의 단편, 상기 GRS 단백질 또는 이의 단편을 암호화하는 핵산을 유효성분으로 함유하는 것을 특징으로 하는 항암용 조성물에 관한 것이다. 상기 GRS 단백질 또는 이의 단편은 특이적으로 암세포 사멸을 유도하는 활성이 우수하므로 이를 함유하거나 상기 GRS 단백질 또는 이의 단편을 암호화하는 핵산을 함유하는 본 발명의 조성물은 항암용으로 유용하게 사용될 수 있다.
PCT/KR2009/005829 2008-10-10 2009-10-12 Grs 단백질 또는 이의 단편의 신규한 용도 WO2010041913A2 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP09819420.2A EP2351575B1 (en) 2008-10-10 2009-10-12 Grs for use in treating a cancer
US13/123,522 US8901081B2 (en) 2008-10-10 2009-10-12 Uses of GRS proteins or fragments thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20080099784 2008-10-10
KR10-2008-0099784 2008-10-10

Publications (3)

Publication Number Publication Date
WO2010041913A2 WO2010041913A2 (ko) 2010-04-15
WO2010041913A3 true WO2010041913A3 (ko) 2010-08-05
WO2010041913A9 WO2010041913A9 (ko) 2010-10-07

Family

ID=42101119

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/005829 WO2010041913A2 (ko) 2008-10-10 2009-10-12 Grs 단백질 또는 이의 단편의 신규한 용도

Country Status (4)

Country Link
US (1) US8901081B2 (ko)
EP (1) EP2351575B1 (ko)
KR (1) KR101102485B1 (ko)
WO (1) WO2010041913A2 (ko)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8969301B2 (en) 2010-07-12 2015-03-03 Atyr Pharma Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-tRNA synthetases
US9034598B2 (en) 2010-05-17 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
US9322009B2 (en) 2010-06-01 2016-04-26 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases
US9453214B2 (en) 2009-02-27 2016-09-27 Atyr Pharma, Inc. Polypeptide structural motifs associated with cell signaling activity
US9528103B2 (en) 2010-04-27 2016-12-27 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
US9540628B2 (en) 2009-12-11 2017-01-10 Atyr Pharma, Inc. Aminoacyl tRNA synthetases for modulating inflammation
US9593323B2 (en) 2010-05-03 2017-03-14 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2727622A1 (en) * 2008-06-11 2009-12-17 Atyr Pharma, Inc. Thrombopoietic activity of tyrosyl-trna synthetase polypeptides
JP5756751B2 (ja) 2008-06-26 2015-07-29 エータイアー ファーマ， インコーポレイテッド 非正準的な生物学的活性を有するグリシル−ｔＲＮＡ合成酵素を含む組成物および方法
DK3255146T3 (da) 2009-03-16 2019-08-19 Pangu Biopharma Ltd Præparater og fremgangsmåder omfattende histidyl-tRNA-synthetasesplejsningsvarianter med ikke-kanoniske biologiske aktiviteter
AU2010236913B2 (en) * 2009-03-31 2016-03-24 Atyr Pharma, Inc. Compositions and methods comprising aspartyl-tRNA synthetases having non-canonical biological activities
US8828395B2 (en) 2009-12-11 2014-09-09 Atyr Pharma, Inc. Antibodies that bind tyrosyl-tRNA synthetases
WO2011072266A2 (en) * 2009-12-11 2011-06-16 Atyr Pharma, Inc. Aminoacyl trna synthetases for modulating hematopoiesis
AU2011248625B2 (en) 2010-04-26 2017-01-05 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
JP6240500B2 (ja) 2010-04-27 2017-11-29 エータイアー ファーマ， インコーポレイテッド スレオニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
CA2797271C (en) 2010-04-28 2021-05-25 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
CA2797393C (en) 2010-04-29 2020-03-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
CN103097523B (zh) 2010-04-29 2016-09-28 Atyr医药公司 与天冬酰胺酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
ES2668207T3 (es) 2010-05-03 2018-05-17 Atyr Pharma, Inc. Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de metionil-ARNt sintetasas
CN103096925A (zh) 2010-05-03 2013-05-08 Atyr医药公司 与精氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
JP6039546B2 (ja) 2010-05-03 2016-12-07 エータイアー ファーマ， インコーポレイテッド セリルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
CN102985103A (zh) 2010-05-04 2013-03-20 Atyr医药公司 与p38多-tRNA合成酶复合物相关的治疗、诊断和抗体组合物的创新发现
CN103096909A (zh) 2010-05-04 2013-05-08 Atyr医药公司 与谷氨酰-脯氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
US8945541B2 (en) 2010-05-14 2015-02-03 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
EP2575856B1 (en) 2010-05-27 2017-08-16 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
JP6177129B2 (ja) 2010-07-12 2017-08-09 エータイアー ファーマ， インコーポレイテッド ヒスチジルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
WO2012021247A2 (en) 2010-07-12 2012-02-16 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
CA2808539C (en) 2010-08-25 2021-05-25 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases
US9399770B2 (en) 2010-10-06 2016-07-26 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tryptophanyl-tRNA synthetases
US9673102B2 (en) * 2011-04-01 2017-06-06 Micron Technology, Inc. Methods of forming vertical field-effect transistor with self-aligned contacts for memory devices with planar periphery/array and intermediate structures formed thereby
US20160144003A1 (en) * 2011-05-19 2016-05-26 The Scripps Research Institute Compositions and methods for treating charcot-marie-tooth diseases and related neuronal diseases
US9714419B2 (en) 2011-08-09 2017-07-25 Atyr Pharma, Inc. PEGylated tyrosyl-tRNA synthetase polypeptides
KR101398079B1 (ko) * 2011-10-10 2014-05-27 재단법인 의약바이오컨버젼스연구단 글리실-티알엔에이 합성효소 및 캐드헤린을 이용한 암 예방 또는 치료제의 스크리닝 방법
WO2013086228A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Pegylated aspartyl-trna synthetase polypeptides
WO2013086216A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Improved aspartyl-trna synthetases
AU2012368189B2 (en) 2011-12-29 2017-08-31 Atyr Pharma, Inc. Aspartyl-tRNA synthetase-Fc conjugates
US8835387B2 (en) 2012-02-16 2014-09-16 Atyr Pharma, Inc. Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
KR101580681B1 (ko) * 2013-02-28 2015-12-29 재단법인 의약바이오컨버젼스연구단 글라이실-tRNA 합성효소를 포함하는 마이크로베지클의 제조방법
ES2708565T3 (es) 2013-03-15 2019-04-10 Atyr Pharma Inc Conjugados de Fc-histidil-ARNt sintetasa
WO2015183018A1 (ko) 2014-05-28 2015-12-03 재단법인 의약바이오컨버젼스연구단 아미노아실 티알엔에이 합성효소를 포함하는 나노파티클 및 이를 포함하는 항암용 조성물
WO2018195338A1 (en) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
KR102167755B1 (ko) * 2018-05-23 2020-10-19 주식회사 큐어바이오 단편화된 grs 폴리펩타이드, 이의 변이체 및 이들의 용도

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506607B1 (en) * 1997-12-24 2003-01-14 Millennium Pharmaceuticals, Inc. Methods and compositions for the identification and assessment of prostate cancer therapies and the diagnosis of prostate cancer
WO2004038020A1 (en) * 2002-06-07 2004-05-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Target genes for the diagnosis and treatment of cancer
WO2005019258A2 (en) * 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
EP0502036B1 (en) 1989-11-22 1995-12-20 Genentech, Inc. Latency associated peptide and uses therefor
CN1330144A (zh) 2000-06-19 2002-01-09 上海博德基因开发有限公司 一种新的多肽——人I类氨酰基－tRNA合成酶10和编码这种多肽的多核苷酸
CN1620305A (zh) 2001-12-14 2005-05-25 株式会社盛多利 诱导凋亡的方法和诱导凋亡的组合物
JP5033471B2 (ja) 2007-05-09 2012-09-26 住友化学株式会社 有機化合物の結晶およびその製造方法
JP5756751B2 (ja) * 2008-06-26 2015-07-29 エータイアー ファーマ， インコーポレイテッド 非正準的な生物学的活性を有するグリシル−ｔＲＮＡ合成酵素を含む組成物および方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506607B1 (en) * 1997-12-24 2003-01-14 Millennium Pharmaceuticals, Inc. Methods and compositions for the identification and assessment of prostate cancer therapies and the diagnosis of prostate cancer
WO2004038020A1 (en) * 2002-06-07 2004-05-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Target genes for the diagnosis and treatment of cancer
WO2005019258A2 (en) * 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
SHIBA K ET AL.: "Human glycyl-tRNA synthetase. Wide divergence of primary structure from bacterial counterpart and species-specific aminoacylation.", J BIOL CHEM., vol. 269, no. 47, 25 November 1994 (1994-11-25), pages 30049 - 30055, XP008146986 *
WASENIUS VM ET AL.: "Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.", CLIN CANCER RES., vol. 9, no. 1, January 2003 (2003-01-01), pages 68 - 75, XP008146998 *
WILLIAMS J ET AL.: "Cloning, sequencing and bacterial expression of human glycine tRNA synthetase.", NUCLEIC ACIDS RES., vol. 23, no. 8, 25 April 1995 (1995-04-25), pages 1307 - 1310, XP008147113 *
YANO S ET AL.: "Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer.", ONCOL REP., vol. 15, no. 6, June 2006 (2006-06-01), pages 1453 - 1460, XP008146997 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9453214B2 (en) 2009-02-27 2016-09-27 Atyr Pharma, Inc. Polypeptide structural motifs associated with cell signaling activity
US9540628B2 (en) 2009-12-11 2017-01-10 Atyr Pharma, Inc. Aminoacyl tRNA synthetases for modulating inflammation
US9528103B2 (en) 2010-04-27 2016-12-27 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
US9593323B2 (en) 2010-05-03 2017-03-14 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
US9034598B2 (en) 2010-05-17 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
US9322009B2 (en) 2010-06-01 2016-04-26 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases
US8969301B2 (en) 2010-07-12 2015-03-03 Atyr Pharma Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-tRNA synthetases

Also Published As

Publication number Publication date
US20110256119A1 (en) 2011-10-20
KR20100040697A (ko) 2010-04-20
US8901081B2 (en) 2014-12-02
KR101102485B1 (ko) 2012-01-05
EP2351575B1 (en) 2016-12-14
WO2010041913A9 (ko) 2010-10-07
EP2351575A4 (en) 2013-04-03
WO2010041913A2 (ko) 2010-04-15
EP2351575A2 (en) 2011-08-03

Similar Documents

Publication Publication Date Title
WO2010041913A3 (ko) Grs 단백질 또는 이의 단편의 신규한 용도
MX2014007233A (es) Composiciones de nucleosidos, nucleotidos y acidos nucleicos modificados.
WO2013006953A8 (en) Genes and proteins for alkanoyl-coa synthesis
WO2011106770A3 (en) Modified proteins and methods of making and using same
WO2013067349A9 (en) Novel chemistry used in biosensors
UA94417C2 (ru) Замещенные 7-азаиндазолы, композиция, которая их содержит, и применение
WO2011139702A3 (en) Modified nucleosides and oligomeric compounds prepared therefrom
WO2011082273A3 (en) Substituted pyrrolo-aminopyrimidine compounds
GB201020995D0 (en) Biological materials and uses thereof
WO2011079902A3 (en) Biological inhibitors of ror1 capable of inducing cell death
WO2011082270A3 (en) Substituted imidazopyridinyl-aminopyridine compounds
WO2014028429A3 (en) Enzymes and polymerases for the synthesis of rna
MY162737A (en) 4-1bb binding molecules
WO2011082267A3 (en) Substituted triazolo-pyrazine compounds
WO2011082266A3 (en) Substituted heterocyclic compounds
WO2011008495A3 (en) Arginase formulations and methods
WO2008085221A3 (en) Therapeutic use of cd31 expressing cells
WO2009135646A3 (en) Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
WO2011135461A3 (en) Clay compositions
WO2011123678A3 (en) Substituted benzo-pyrido-triazolo-diazepine compounds
UA105073C2 (uk) Антитіло проти фракталкіну, композиція і спосіб для лікування запальних порушень
WO2009062576A3 (en) Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
WO2012136898A3 (en) Novel cutinases, their production and uses
WO2011082268A3 (en) Substituted naphthalenyl-pyrimidine compounds
IN2015DN03206A (ko)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09819420

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2009819420

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2009819420

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 13123522

Country of ref document: US